Skip to content

Clinical trials

Drug Resistant Epilepsy trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Country / region: Italy Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20183
20193
20203
20211
20224
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Terminated5
Unknown status3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
PTC Therapeutics2
UCB Biopharma SRL2
Azienda Usl di Bologna1
Danone Nutricia SpA Società Benefit1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
IRCCS Eugenio Medea1
IRCCS San Raffaele1
LivaNova1
MedtronicNeuro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy21
Epilepsy11
Seizures8
Epilepsies, Partial4
Diffuse Cerebral Sclerosis of Schilder2
Leigh Disease2
MELAS Syndrome2
MERRF Syndrome2
Aneurysm1
Arteriovenous Malformations1

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.